Showing results (101-110 of 243) with videos related to
Sort By:
Pageof 25
Neoreviews|April 30, 2024
Nosocomial Infections in the Neonatal Intensive Care UnitDaisy Marty, Kirsten Sorum, Kevin Smith, et al.Journal of the American College of Radiology : JACR|March 7, 2013
Introducing first-year radiology residents to the ACR at the AMCLC from 2009-2011: the potential impact for ACR and state radiological society membershipsRyan Brady, Brendan McMenomy, Anil Chauhan, et al.International Journal of Integrated Care|December 18, 2023
Integrated Care: A Person-Centered and Population Health Strategy for the COVID-19 Pandemic Recovery and BeyondAyodele Odutayo, Kevin Smith, Carolyn Gosse, et al.Toxins|February 21, 2019
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in PatientsMalgorzata Field, Andrew Splevins, Philippe Picaut, et al.Toxins|December 16, 2018
AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in PatientsMalgorzata Field, Andrew Splevins, Philippe Picaut, et al.The International Journal of Neuroscience|January 19, 2018
A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystoniaMark F Lew, Allison Brashear, Khashayar Dashtipour, et al.Advances in Therapy|March 23, 2024
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims AnalysisBenjamin Chastek, Adam Carrera, Christina Landis, et al.Neurourology and Urodynamics|May 9, 2024
Comparative analysis of real-world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims studyBenjamin Chastek, Adam Carrera, Christina Landis, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Evaluation of a commercial rule engine as a basis for a clinical decision support serviceHoward S Goldberg, Michael Vashevko, Anatoly Pastilnik, et al.Radiology|December 18, 2019
Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk PredictionKarin Dembrower, Yue Liu, Hossein Azizpour, et al.Pageof 25